30,544 Shares in Colgate-Palmolive (NYSE:CL) Acquired by FORA Capital LLC

FORA Capital LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 30,544 shares of the company's stock, valued at approximately $2,777,000.

A number of other institutional investors have also recently bought and sold shares of the business. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $26,000. Centricity Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $27,000. Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $32,000. Briaud Financial Planning Inc acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $32,000. Finally, Wintrust Investments LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $33,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Trading Down 1.0%

NYSE:CL traded down $0.92 on Friday, hitting $89.91. 3,846,241 shares of the stock were exchanged, compared to its average volume of 4,631,100. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock has a market capitalization of $72.86 billion, a price-to-earnings ratio of 25.54, a P/E/G ratio of 4.20 and a beta of 0.39. The company's 50-day moving average price is $92.21 and its 200 day moving average price is $91.47. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. The company had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. Colgate-Palmolive's revenue was down 3.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.86 EPS. On average, equities research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.31%. Colgate-Palmolive's dividend payout ratio is 58.76%.

Colgate-Palmolive announced that its Board of Directors has approved a share repurchase plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the company to purchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's board of directors believes its stock is undervalued.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of research analyst reports. JPMorgan Chase & Co. lifted their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a report on Monday, April 28th. Morgan Stanley cut their price target on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a report on Monday, February 3rd. Raymond James reaffirmed an "outperform" rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Stifel Nicolaus cut their price target on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a report on Monday, February 3rd. Finally, Barclays cut their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a report on Friday, April 11th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $102.39.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.